<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl1" position="float"><object-id pub-id-type="doi">10.7554/eLife.25751.005</object-id><label>Table 1.</label><caption><p>Motor neuron subclass markers.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.25751.005">http://dx.doi.org/10.7554/eLife.25751.005</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th>Gene</th><th>Function</th><th>Previously reported subclass expression</th><th>Confirmed subclass expression</th><th>Revised/new subclass expression</th><th>Stage for onset of expression <break/>(in hermaphrodites)</th><th>Sex-specificity of expression</th><th valign="top"> <break/><break/>UNC-3 dependency and COE motif number</th></tr></thead><tbody><tr><td><italic>del-1</italic></td><td>DEG/ENaC ion channel</td><td>VA1-VA12 <break/>VB1-VB11 SABVL/R*</td><td><break/></td><td>VA1-VA11 <break/>VB1-VB11 <break/>SABVL/R<sup>&#8224;</sup></td><td>VA1-VA11: late L2<sup>&#8225;</sup> <break/>VB1-VB11: early L2 <break/>SABVL/R: 3-fold embryo</td><td>Yes, in males VA12 also express <italic>del-1</italic></td><td>Yes (3 motifs)</td></tr><tr><td><italic>unc-129</italic></td><td>TGF-beta like molecule</td><td>DA1-DA7, DB1-DB7, SABD<sup>&#167;</sup></td><td>DA1-DA7, DB1-DB7, SABD<sup>#</sup></td><td><break/></td><td>DA1-DA7, DB1-DB7, SABD: L1</td><td>No</td><td>Yes (3 motifs)</td></tr><tr><td><italic>hum-2</italic></td><td>unconventional myosin</td><td>DB1<sup>&#182;</sup></td><td>DB1**</td><td><break/></td><td>DB1: L1 or earlier</td><td>No</td><td>N. D (1 motif)</td></tr><tr><td><italic>bnc-1</italic></td><td>C2H2 Zn finger transcription factor</td><td>VA1-VA12, VB2-VB11, SABVL/R<sup>&#8224;&#8224;</sup></td><td>VA1-VA12, VB2-VB11, SABVL/R<sup>&#8225;&#8225;</sup></td><td><break/></td><td>VA1-VA12, VB2-VB11, SABVL/R: late L1</td><td>Yes, CP7 and CP8<sup>&#8224;&#8224;</sup> in male VNC</td><td>Yes<sup>7</sup> (4 motifs)</td></tr><tr><td><italic>cfi-1</italic></td><td>ARID-type transcription factor</td><td>DA1-DA8<sup>&#167;&#167;</sup>, DB1-DB7</td><td>DA1-DA8<sup>##</sup>, DB1-DB7</td><td>VA2-VA11, VB3-VB11<sup>##</sup></td><td>DA1-DA8: not determined <break/>VA2-11, VB3-VB11: late L1</td><td>Not determined</td><td>Yes (&gt;5 motifs)</td></tr><tr><td><italic>avr-15</italic></td><td>Glutamate-gated cloride channel</td><td>DA9, VA12<sup>&#182;&#182;</sup></td><td><break/></td><td>VA11, AS11***</td><td>VA11, AS11: late L3</td><td>Yes, 4 additional neurons (not ACh) in male PAG</td><td>Yes (4 motif)</td></tr><tr><td><italic>flp-18</italic></td><td>FMRF-like neuropeptide</td><td>none</td><td><break/></td><td>VA11 <break/>VA12<sup>&#8224;&#8224;&#8224;</sup></td><td>VA11: L2/L3 <break/>VA12: L2/L3</td><td>Yes, 8 additional cells/neurons in male tail</td><td>Yes (1 motif)</td></tr><tr><td><italic>ser-2</italic></td><td>tyramine receptor</td><td>DA9<sup>&#8225;&#8225;&#8225;</sup></td><td><break/></td><td>DA8<sup>&#167;&#167;&#167;</sup></td><td>DA8: L1 or earlier</td><td>No</td><td>No (0 motifs)</td></tr><tr><td><italic>mig-13</italic></td><td>transmembrane protein</td><td>DA9, VA12<sup>###</sup></td><td>DA9 <break/>VA12<sup>&#182;&#182;&#182;</sup></td><td><break/></td><td>DA9: L1 or earlier <break/>VA12: L2</td><td>Yes, 2 additional ACh tail neurons</td><td>Yes (1 motif)</td></tr><tr><td><italic>glr-4</italic></td><td>Glutamate receptor subunit</td><td>none</td><td><break/></td><td>DA9****</td><td>DA9: L1 or earlier</td><td>No</td><td>Yes (2 motifs)</td></tr><tr><td><italic>itr-1</italic></td><td>Inositol triphosphate receptor</td><td>PDA, DA9<sup>&#8224;&#8224;&#8224;&#8224;</sup></td><td><break/></td><td>DA9<sup>&#8224;&#8224;&#8224;&#8224;</sup></td><td>DA9: L2/L3</td><td>No</td><td>Yes (1 motif)</td></tr><tr><td><italic>sra-36</italic></td><td>G-protein coupled receptor</td><td>none</td><td><break/></td><td>DA8 <break/>DA9 <break/>VA11<sup>&#8225;&#8225;&#8225;&#8225;</sup></td><td>DA8, DA9: L1 or earlier <break/>VA11: L2</td><td>No</td><td>N. D (2 motifs)</td></tr></tbody></table><table-wrap-foot><fn id="tblfn1"><p>*Reagent: <italic>wdIs3 X or wdIs6 II [del-1<sup>prom</sup>::gfp]</italic>; <xref ref-type="bibr" rid="bib94">Winnier et al., 1999</xref>.</p></fn><fn id="tblfn2"><p><sup>&#8224;</sup>Expression was confirmed in VA1-11, VB1-11, and SABVL/R based on cell body position, axonal trajectory, and expected number of neurons for each class. Also, see <xref ref-type="fig" rid="fig2">Figure 2C</xref>.</p></fn><fn id="tblfn3"><p><sup>&#8225;</sup>As described in <xref ref-type="bibr" rid="bib94">Winnier at al. (1999)</xref>, by the end of L2, <italic>del-1<sup>prom</sup>::gfp</italic> is visible in a few anterior VAs. This expression progresses in a wave from anterior to posterior VAs, with all VAs (except VA12) expressing <italic>del-1<sup>prom</sup>::gfp</italic> by the L4/adult stage.</p></fn><fn id="tblfn4"><p><sup>&#167;</sup>Reagent: evIs82B IV <italic>[unc-129<sup>prom</sup>::gfp]</italic>; <xref ref-type="bibr" rid="bib12">Colavita et al. (1998)</xref>, <xref ref-type="bibr" rid="bib48">Kratsios et al. (2015)</xref></p></fn><fn id="tblfn5"><p><sup>#</sup>Expression was confirmed in DA1-7, DB1-7, and SABD based on cell body position, axonal trajectory, cell type-specific markers, and expected number of neurons for each class. Also, see <xref ref-type="fig" rid="fig2">Figure 2C</xref>.</p></fn><fn id="tblfn6"><p><sup>&#182;</sup>Reagent: <italic>mdIs123 [hum-2<sup>prom</sup>::gfp]</italic> from James Rand and Stephen Fields; <ext-link ext-link-type="uri" xlink:href="http://www.wormatlas.org">www.wormatlas.org</ext-link></p></fn><fn id="tblfn7"><p>**Expression was confirmed in DB1 based on cell body position and axonal trajectory. Also, see <xref ref-type="fig" rid="fig1">Figure 1B</xref>.</p></fn><fn id="tblfn8"><p><sup>&#8224;&#8224;</sup>Reagent: <italic>bnc-1 (ot845[bnc-1::+mNG+AID])</italic> CRISPR allele; <xref ref-type="bibr" rid="bib46">Kerk et al., 2017</xref>.</p></fn><fn id="tblfn9"><p><sup>&#8225;&#8225;</sup>Expression was confirmed in VA1-VA12, VB2-VB11, SABVL/R based on cell body position and expected number of neurons for each class.</p></fn><fn id="tblfn10"><p><sup>&#167;&#167;</sup>Reagent: <italic>otEx6502 [cfi-1<sup>fosmid</sup>::gfp];</italic> <xref ref-type="bibr" rid="bib46">Kerk et al., 2017</xref>.</p></fn><fn id="tblfn11"><p><sup>##</sup>Expression was confirmed in DA1-8 based on cell body position and the cell-type specific markers <italic>juIs14[acr-2::gfp]</italic> that labels DA, DB, VA, VB. This analysis also revealed that <italic>cfi-1</italic> is not expressed in VA12. No expression in VA1, VB1 and VB2 was inferred based on cell body position and total number (3) of MNs expressing <italic>cfi-1</italic> at the retrovesicular ganglion.</p></fn><fn id="tblfn12"><p><sup>&#182;&#182;</sup>Reagent: <italic>adEx1299[avr-15<sup>prom</sup>::gfp];</italic> <xref ref-type="bibr" rid="bib16">Dent et al., 1997</xref>.</p></fn><fn id="tblfn13"><p>***Expression was confirmed in AS11 based on cell body position, axonal trajectory, and cell type-specific markers. Also, see Figure 9D&#8211;E and <xref ref-type="fig" rid="fig1s1">Figure 1-figure supplement 1</xref> .</p></fn><fn id="tblfn14"><p><sup>&#8224;&#8224;&#8224;</sup>Reagent: <italic>ynIs59[flp-18<sup>prom</sup>::gfp]</italic> from Chris Li. Expression in VA11 and VA12 was confirmed with cell type-specific markers. Also, see <xref ref-type="fig" rid="fig1">Figure 1B</xref>, <xref ref-type="fig" rid="fig2">Figure 2A&#8211;B</xref>, and <xref ref-type="fig" rid="fig1s1">Figure 1&#8212;figure supplement&#160;1</xref>.</p></fn><fn id="tblfn15"><p><sup>&#8225;&#8225;&#8225;</sup>Reagent: <italic>otIs107 [ser-2<sup>prom1</sup>::gfp]</italic>; <xref ref-type="bibr" rid="bib84">Tsalik et al., 2003</xref>.</p></fn><fn id="tblfn16"><p><sup>&#167;&#167;&#167;</sup>Expression in DA8 was confirmed with cell type-specific markers. Also, see <xref ref-type="fig" rid="fig1">Figure 1B</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1&#8212;figure supplement 1</xref>.</p></fn><fn id="tblfn17"><p><sup>###</sup>Reagent: <italic>muIs42[mig-13<sup>prom</sup>::MIG-13::gfp];</italic> <xref ref-type="bibr" rid="bib82">Sym et al., 1999</xref>, <xref ref-type="bibr" rid="bib47">Klassen and Shen (2007)</xref></p></fn><fn id="tblfn18"><p><sup>&#182;&#182;&#182;</sup>Expression in DA9 and VA12 was confirmed with cell type-specific markers. Also, see <xref ref-type="fig" rid="fig2">Figure 2A&#8211;B</xref>.</p></fn><fn id="tblfn19"><p>****Reagent: <italic>otIs476[glr-4<sup>prom</sup>::tagrfp].</italic> Expression in DA9 was confirmed with cell type-specific markers. Also, see <xref ref-type="fig" rid="fig1s1">Figure 1&#8212;figure supplement&#160;1</xref>.</p></fn><fn id="tblfn20"><p><sup>&#8224;&#8224;&#8224;&#8224;</sup>Reagent: <italic>otIs453 [itr-1<sup>prom</sup>::gfp].</italic> Plasmid used for otIs453 transgene is pBT001, which was generated by <xref ref-type="bibr" rid="bib28">Gower et al., 2001</xref> and <italic>gfp</italic> expression in <italic>C.elegans</italic> in DA9 and PDA is described in <xref ref-type="bibr" rid="bib28">Gower et al., 2001</xref> and <xref ref-type="bibr" rid="bib47">Klassen and Shen (2007)</xref>. Expression was confirmed in DA9 using cell type-specific markers. Also, see <xref ref-type="fig" rid="fig2">Figure 2A&#8211;B</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1&#8212;figure supplement 1</xref>.</p></fn><fn id="tblfn21"><p><sup>&#8225;&#8225;&#8225;&#8225;</sup>Reagent: <italic>sEx11976[sra-36<sup>prom</sup>::gfp]</italic>. Expression in VA11, DA8 and DA9 was confirmed with cell type-specific markers. Also, see <xref ref-type="fig" rid="fig1">Figure 1B</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1&#8212;figure supplement 1</xref>. <sup>&#8224;, #,</sup> **<sup>, &#8225;&#8225;, ##, &#182;&#182;, &#8224;&#8224;&#8224;, &#167;&#167;&#167;, ###,</sup> ****<sup>, &#8224;&#8224;&#8224;&#8224;</sup>See also &#8216;Motor Neuron Subclass Identification&#8217; section in Materials&#160;and&#160;methods.</p></fn><fn id="tblfn22"><p>N. D: Not determined.</p></fn></table-wrap-foot></table-wrap>